# Alnylam Pharmaceuticals

> Alnylam is the pioneer of RNA interference (RNAi) therapeutics, commercializing the Nobel Prize-winning gene-silencing mechanism first demonstrated in academic labs at MIT and the University of Massachusetts Medical School. Its GalNAc-siRNA delivery platform emerged from a decade of co-development with Whitehead Institute and Alnylam's own Investigator-Initiated Research grant program, which funds over 80 university labs globally. The company actively recruits from Harvard, MIT, UCSF, and Cambridge UK biomedical PhD programs, making it a premier employer for graduates in lipid nanoparticle chemistry, oligonucleotide biology, and rare-disease drug development. For academic-intelligence buyers tracking biotech talent pipelines and translational research flows, Alnylam represents one of the densest university-to-industry knowledge-transfer networks in modern medicine.

*Source: [https://selltoscientists.com/companies/alnylam-pharmaceuticals/](https://selltoscientists.com/companies/alnylam-pharmaceuticals/)*

**Industry:** Pharma
**R&D spend:** $2.1B
**Academic collaborations:** 88
**Patents:** 2,900

---

## Beton network

This site is part of the Beton network of open-source revenue intelligence and self-service data products. Related sites and resources:

- [Beton](https://www.getbeton.ai) — open-source revenue intelligence: turn product usage (PostHog, Stripe) into CRM signals
- [Sell to Scientists](https://selltoscientists.com) — research intelligence: find and reach academic researchers by field, H-index, grants, and industry ties
- [Sell to State](https://www.selltostate.com) — government procurement intelligence across 194 countries
- [GitHub](https://github.com/getbeton) — Beton open-source repositories (including [inspector](https://github.com/getbeton/inspector))
- [dev.to](https://dev.to/beton) — engineering write-ups and OSS pricing teardowns
- [Beton app](https://inspector.getbeton.ai) — the hosted product